Ho, C., & Spry, C. (2017). Rituximab for granulomatosis with polyangiitis or microscopic polyangiitis: A review of the clinical effectiveness, cost-effectiveness, and guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health.
Chicago Style CitationHo, Chuong, and Carolyn Spry. Rituximab for Granulomatosis With Polyangiitis or Microscopic Polyangiitis: A Review of the Clinical Effectiveness, Cost-effectiveness, and Guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.
MLA CitationHo, Chuong, and Carolyn Spry. Rituximab for Granulomatosis With Polyangiitis or Microscopic Polyangiitis: A Review of the Clinical Effectiveness, Cost-effectiveness, and Guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.